Amniotic Membrane Market Forecast to 2030

Description

Amniotic Membrane Market Analysis

Amniotic Membrane Market Forecast to 2030

Market Overview

The amniotic membrane (AM), the innermost layer of the placenta, is made up of cells and tissues that act as a mechanism for soft tissue regeneration after a wound. The amniotic membrane contains biologically active cells that secrete growth factors and cytokines with anti-inflammatory, anti-immunogenic, and anti-fibrotic qualities. These cells are found in both the epithelial and stromal layers. The market is also expanding for amniotic membrane eye treatments. The amniotic membrane market study states that recent growth in tissue-based products is attributable to higher transplant rates brought on by more awareness.
The industry is expanding because of more donations brought about by increased awareness. Amniotic membranes are frequently used for a variety of conditions, including pressure and venous leg ulcers, corneal ulcers, limbal stem cell deficiency, pterygium excisions, surgical wounds, and regenerative medicine. Without a doubt, the industry will grow swiftly and consistently. The development of amniotic membrane in the field of amniotic membrane ophthalmology is also being researched and studied, as is the amniotic membrane transplantation technique that will be used in the future.

Segment Overview

The market for amniotic membranes is divided into two product categories: cryopreserved and dehydrated amniotic membrane respectively. The amniotic membrane market is segmented based on its application, which includes surgical wounds, ophthalmology, and others.

Regional Analysis

The amniotic membrane market has been divided into four regions: Asia-Pacific, North America, Europe and other countries. North America having the major share of the market and is expected to continue to do so in the coming years due to the presence of leading industry players and well-established healthcare facilities. Meanwhile, Europe is projected to have the highest growth rate and largest market share by the end of the forecast period, thanks to public funding for the healthcare system and the implementation of universal healthcare systems in several countries. The market for amniotic membrane is also expected to grow in other parts of the world. The target end-users for this market include hospitals, ambulatory surgical centers, specialty clinics, and academic and research institutions.

Major Player

s
Amniotic Membrane market leading companies consist of Alliqua BioMedical Inc.; Human Regenerative Technologies, LLC; Applied Biologics, LLC; DermaSciences; Amniox Medical Inc.; Amnio Technology, LLC; Skye Biologics, Inc.; MiMedx Group Inc.; and Organogensis, Inc.

COVID 19 Impacts

The market suffered from the COVID-19 pandemic. The limited capacities and resources (such as patient care specialists and hospital beds) were being reserved or redistributed toward COVID-19 patient care; therefore, elective surgeries were being refused (cancelled/postponed). Curfews and lockdowns have also been enforced in numerous countries to combat the escalating COVID-19 cases. Patients were unable to visit clinics, hospitals, or OPDs as a result of these lockdowns. This temporary ban on non-emergent healthcare services constrained the expansion of the amniotic membranes market. However, it is projected that the need for amniotic products would rise over the future years.

TABLE OF CONTENT

1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION 15
2.2 SCOPE OF THE STUDY 15
2.3 ASSUMPTIONS & LIMITATIONS 15
2.3.1 ASSUMPTIONS 15
2.3.2 LIMITATIONS 15
2.4 MARKET STRUCTURE 16
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 INTRODUCTION 26
4.2 DRIVERS 27
4.2.1 RISING AMNIOTIC MEMBRANE TRANSPLANTATIONS 27
4.2.2 RAPID GROWTH IN THE GERIATRIC POPULATION 27
4.2.3 INCREASING RESEARCH ACTIVITIES 28
4.3 RESTRAINTS 28
4.3.1 RISING HEALTHCARE COST 28
4.3.2 STRINGENT REGULATORY POLICIES 28
4.4 OPPORTUNITIES 29
4.4.1 ENTERING DEVELOPING ECONOMIES 29
4.4.2 INCREASING AWARENESS ABOUT THE ADVANTAGES OF AMNIOTIC MEMBRANE TRANSPLANT 29
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 30
5.1.1 R&D 30
5.1.2 MANUFACTURING 30
5.1.3 DISTRIBUTION & SALES 30
5.1.4 POST-SALES MONITORING 31
5.2 PORTER’S FIVE FORCES ANALYSIS 31
5.2.1 BARGAINING POWER OF SUPPLIERS 31
5.2.2 BARGAINING POWER OF BUYERS 32
5.2.3 THREAT OF NEW ENTRANTS 32
5.2.4 THREAT OF SUBSTITUTES 32
5.2.5 INTENSE RIVALRY 32
5.3 INVESTMENT OPPORTUNITIES 33
5.4 PRICING ANALYSIS 33
6 AMNIOTIC MEMBRANE MARKET, BY TYPE
6.1 OVERVIEW 34
6.2 CRYOPRESERVATION AMNIOTIC MEMBRANE 35
6.3 LYOPHILIZED AMNIOTIC MEMBRANE 36
7 AMNIOTIC MEMBRANE MARKET, BY APPLICATION
7.1 OVERVIEW 37
7.2 SURGICAL WOUNDS 38
7.3 OPHTHALMOLOGY 39
7.4 STEM CELL BIOLOGY 39
7.5 REGENERATIVE MEDICINE 40
7.6 PRENATAL DIAGNOSIS 41
7.7 OTHERS 41
8 AMNIOTIC MEMBRANE MARKET, BY END USER
8.1 OVERVIEW 42
8.2 HOSPITAL & CLINICS 43
8.3 AMBULATORY SURGICAL CENTERS 44
8.4 RESEARCH CENTERS AND LABORATORY 45
8.5 OTHERS 45
9 GLOBAL AMNIOTIC MEMBRANE MARKET, BY REGION
9.1 OVERVIEW 46
9.2 AMERICAS 48
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.2.1 NORTH AMERICA 50
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.2.1.1 US 52
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.2.1.2 CANADA 53
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.2.2 LATIN AMERICA 54
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3 EUROPE 55
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.1 WESTERN EUROPE 57
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.1.1 GERMANY 59
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.1.2 FRANCE 60
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.1.3 UK 61
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.1.4 ITALY 62
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.1.5 SPAIN 63
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.1.6 REST OF WESTERN EUROPE 64
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.3.2 EASTERN EUROPE 65
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.4 ASIA-PACIFIC 67
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.4.1 JAPAN 69
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.4.2 CHINA 70
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.4.3 INDIA 71
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.4.4 SOUTH KOREA 72
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.4.5 AUSTRALIA 73
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.4.6 REST OF ASIA-PACIFIC 74
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.5 MIDDLE EAST & AFRICA 75
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.5.1 MIDDLE EAST 77
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
9.5.2 AFRICA 78
AMNIOTIC MEMBRANE MARKET, BY TYPE
AMNIOTIC MEMBRANE MARKET, BY APPLICATION
AMNIOTIC MEMBRANE MARKET, BY END USER
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION 79
10.2 COMPANY SHARE ANALYSIS 79
11 COMPANY PROFILES
11.1 APPLIED BIOLOGICS 81
11.1.1 COMPANY OVERVIEW 81
11.1.2 FINANCIAL OVERVIEW 81
11.1.3 PRODUCTS/SERVICES OFFERED 81
11.1.4 KEY DEVELOPMENTS 81
11.1.5 SWOT ANALYSIS 81
11.1.6 KEY STRATEGIES 82
11.2 AQUAMED 83
11.2.1 COMPANY OVERVIEW 83
11.2.2 FINANCIAL OVERVIEW 83
11.2.3 PRODUCTS/SERVICES OFFERED 83
11.2.4 KEY DEVELOPMENTS 84
11.2.5 SWOT ANALYSIS 84
11.2.6 KEY STRATEGIES 84
11.3 INTEGRA LIFESCIENCES 85
11.3.1 COMPANY OVERVIEW 85
11.3.2 FINANCIAL OVERVIEW 85
11.3.3 PRODUCTS/SERVICES OFFERED 86
11.3.4 KEY DEVELOPMENTS 86
11.3.5 SWOT ANALYSIS 86
11.3.6 KEY STRATEGIES 87
11.4 SKYE BIOLOGICS INC. 88
11.4.1 COMPANY OVERVIEW 88
11.4.2 FINANCIAL OVERVIEW 88
11.4.3 PRODUCTS/SERVICES OFFERED 88
11.4.4 KEY DEVELOPMENTS 88
11.4.5 SWOT ANALYSIS 89
11.4.6 KEY STRATEGIES 89
11.5 MIMEDX 90
11.5.1 COMPANY OVERVIEW 90
11.5.2 FINANCIAL OVERVIEW 90
11.5.3 PRODUCTS/SERVICES OFFERED 90
11.5.4 KEY DEVELOPMENTS 91
11.5.5 SWOT ANALYSIS 91
11.5.6 KEY STRATEGIES 91
11.6 AMNIOX MEDICAL, INC. 92
11.6.1 COMPANY OVERVIEW 92
11.6.2 FINANCIAL OVERVIEW 92
11.6.3 PRODUCTS/SERVICES OFFERED 92
11.6.4 KEY DEVELOPMENTS 92
11.6.5 SWOT ANALYSIS 93
11.6.6 KEY STRATEGIES 93
11.7 KATENA PRODUCTS, INC. 94
11.7.1 COMPANY OVERVIEW 94
11.7.2 FINANCIAL OVERVIEW 94
11.7.3 PRODUCTS/SERVICES OFFERED 94
11.7.4 KEY DEVELOPMENTS 94
11.7.5 SWOT ANALYSIS 95
11.7.6 KEY STRATEGIES 95
11.8 HUMAN REGENERATIVE TECHNOLOGIES, LLC 96
11.8.1 COMPANY OVERVIEW 96
11.8.2 FINANCIAL OVERVIEW 96
11.8.3 PRODUCTS/SERVICES OFFERED 96
11.8.4 KEY DEVELOPMENTS 96
11.8.5 SWOT ANALYSIS 96
11.8.6 KEY STRATEGIES 96
11.9 AMNIO TECHNOLOGY, LLC 97
11.9.1 COMPANY OVERVIEW 97
11.9.2 FINANCIAL OVERVIEW 97
11.9.3 PRODUCTS/SERVICES OFFERED 97
11.9.4 KEY DEVELOPMENTS 97
11.9.5 SWOT ANALYSIS 97
11.9.6 KEY STRATEGIES 98
11.10 OSIRIS THERAPEUTICS, INC. 99
11.10.1 COMPANY OVERVIEW 99
11.10.2 FINANCIAL OVERVIEW 99
11.10.3 PRODUCTS/SERVICES OFFERED 99
11.10.4 KEY DEVELOPMENTS 100
11.10.5 SWOT ANALYSIS 100
11.10.6 KEY STRATEGIES 100
12 APPENDIX
12.1 REFERENCES 101
12.2 RELATED REPORTS 101